College of Korean Medicine, Dongguk University, Goyang 10326, Republic of Korea.
Department of Medicine, College of Medicine, Dongguk University, Goyang 10326, Republic of Korea.
J Integr Med. 2021 May;19(3):265-273. doi: 10.1016/j.joim.2020.12.001. Epub 2020 Dec 3.
SC-E3 is a polyherbal formula that contains five medicinal herbs used frequently in traditional herbal medicine. In our previous study, we demonstrated the antioxidant and anti-inflammatory effects of SC-E3. The present study examined the effects of SC-E3 in a mouse model of type-II collagen-induced arthritis (CIA).
In vivo, male DBA/1J mice were immunized by intradermal injection of bovine type-II collagen and complete or incomplete Freund's adjuvant, to induce arthritis. SC-E3 was orally administered daily for 23 days. In vitro, bone marrow-derived macrophages (BMMs) were treated with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-κB ligand (RANKL) in the absence or presence of SC-E3.
Administrations of SC-E3 were found to have anti-arthritic effects in the joints of CIA mice, as evidenced by reduced paw swelling, bone erosion and deformation, inflammatory cell infiltration, and inflammation in synovial membrane. SC-E3 also reduced serum levels of tumor necrosis factor-α, interleukin-1β, aspartate aminotransferase and alanine aminotransferase. Furthermore, tartrate-resistant acid phosphatase-positive osteoclast numbers in the joints were significantly lower in SC-E3-treated CIA mice than in CIA mice. In addition, the differentiations of BMMs to multinucleated osteoclasts induced by M-CSF and RANKL stimulation were dose-dependently reduced by SC-E3.
These results suggest that SC-E3 possesses substantial anti-arthritic activity because it inhibits pro-inflammatory cytokines and osteoclastogenesis, and that SC-E3 has potential therapeutic use for the treatment of rheumatoid arthritis.
SC-E3 是一种复方草药配方,含有五种常用于传统草药的草药。在我们之前的研究中,我们证明了 SC-E3 的抗氧化和抗炎作用。本研究在二型胶原诱导的关节炎(CIA)小鼠模型中研究了 SC-E3 的作用。
体内,雄性 DBA/1J 小鼠通过皮内注射牛二型胶原和完全或不完全弗氏佐剂免疫,诱导关节炎。SC-E3 每天口服给药 23 天。体外,骨髓来源的巨噬细胞(BMM)在巨噬细胞集落刺激因子(M-CSF)和核因子-κB 受体激活剂配体(RANKL)的存在或不存在下用 SC-E3 处理。
SC-E3 的给药被发现对 CIA 小鼠的关节具有抗关节炎作用,表现为爪肿胀、骨侵蚀和变形、炎症细胞浸润和滑膜炎症减少。SC-E3 还降低了血清肿瘤坏死因子-α、白细胞介素-1β、天冬氨酸转氨酶和丙氨酸转氨酶的水平。此外,在 SC-E3 治疗的 CIA 小鼠关节中,抗酒石酸酸性磷酸酶阳性破骨细胞数量明显低于 CIA 小鼠。此外,SC-E3 可剂量依赖性地降低 M-CSF 和 RANKL 刺激诱导的 BMM 向多核破骨细胞的分化。
这些结果表明,SC-E3 具有显著的抗关节炎活性,因为它抑制促炎细胞因子和破骨细胞生成,SC-E3 具有治疗类风湿关节炎的潜在治疗用途。